CellX Biosolutions Analysis: $2M Raised
What is CellX Biosolutions?
Patented bacterial consortia for PFAS, pharmaceuticals, and microplastics degradation
Location
Zurich, Switzerland
Employees
1-10
Founded
2024
Product Features & Capabilities
- Biological treatment of long and short-chain PFAS
- Tailored biodiscovery and treatment solutions for specific chemical effluents
Use Cases
Degradation of PFAS in wastewater from API production; Treatment of pesticide and herbicide by-products in agro-chemical manufacturing; Removal of microplastics from natural water bodies; Custom bacterial solutions for industrial chemical effluents
Other Considerations
Featured in Deutsche Welle and SRF media coverage; Validated by public media for PFAS degradation capabilities; Backed by ETH Zurich research foundation
See something that needs updating? Suggest edits to this profile.